Abstract
The structure-activity relationships of 6-phenyl-1,4-dihydropyridine derivatives as selective antagonists at human A3 adenosine receptors have been explored (Jiang et al. J. Med. Chem. 1997, 39, 4667-4675). In the present study, related pyridine derivatives have been synthesized and tested for affinity at adenosine receptors in radioligand binding assays. Ki values in the nanomolar range were observed for certain 3,5-diacyl-2,4-dialkyl-6-phenylpyridine derivatives in displacement of [125I]AB-MECA (N6-(4-amino-3-iodobenzyl)-5'-N-methylcarbamoyladenosine) at recombinant human A3 adenosine receptors. Selectivity for A3 adenosine receptors was determined vs radioligand binding at rat brain A1 and A2A receptors. Structure-activity relationships at various positions of the pyridine ring (the 3- and 5-acyl substituents and the 2- and 4-alkyl substituents) were probed. A 4-phenylethynyl group did not enhance A3 selectivity of pyridine derivatives, as it did for the 4-substituted dihydropyridines. At the 2- and 4-positions ethyl was favored over methyl. Also, unlike the dihydropyridines, a thioester group at the 3-position was favored over an ester for affinity at A3 adenosine receptors, and a 5-position benzyl ester decreased affinity. Small cycloalkyl groups at the 6-position of 4-phenylethynyl-1,4-dihydropyridines were favorable for high affinity at human A3 adenosine receptors, while in the pyridine series a 6-cyclopentyl group decreased affinity. 5-Ethyl 2, 4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate , 38, was highly potent at human A3 receptors, with a Ki value of 20 nM. A 4-propyl derivative, 39b, was selective and highly potent at both human and rat A3 receptors, with Ki values of 18.9 and 113 nM, respectively. A 6-(3-chlorophenyl) derivative, 44, displayed a Ki value of 7.94 nM at human A3 receptors and selectivity of 5200-fold. Molecular modeling, based on the steric and electrostatic alignment (SEAL) method, defined common pharmacophore elements for pyridine and dihydropyridine structures, e.g., the two ester groups and the 6-phenyl group. Moreover, a relationship between affinity and hydrophobicity was found for the pyridines.
MeSH Terms
Adenosine/analogs & derivatives,metabolism
Animals
Binding, Competitive
Brain/metabolism
Dihydropyridines/chemical synthesis,chemistry,pharmacology
Drug Design
Humans
Iodine Radioisotopes
Kinetics
Models, Molecular
Molecular Conformation
Molecular Structure
Purinergic P1 Receptor Antagonists
Pyridines/chemical synthesis,chemistry,pharmacology
Radioligand Assay
Rats
Receptor, Adenosine A2A
Receptor, Adenosine A3
Recombinant Proteins/antagonists & inhibitors
Structure-Activity Relationship
Chemicals
Dihydropyridines
Iodine Radioisotopes
Purinergic P1 Receptor Antagonists
Pyridines
Receptor, Adenosine A2A
Receptor, Adenosine A3
Recombinant Proteins
N(6)-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide
Adenosine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Li A H
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810, USA.
Moro S
Melman N
Ji X D
Jacobson K A
References (23)
23 references, click to expand
-
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
J Med Chem. 1996 Nov 8;39(23):4667-75
PMID: 8917655
-
Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors.
J Clin Invest. 1996 Oct 15;98(8):1773-9
PMID: 8878427
-
Plasma and urinary metabolites of efonidipine hydrochloride in man.
Xenobiotica. 1996 Feb;26(2):229-39
PMID: 8868006
-
Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
J Med Chem. 1996 Oct 11;39(21):4142-8
PMID: 8863790
-
Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
J Med Chem. 1996 Jul 19;39(15):2980-9
PMID: 8709132
-
Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.
J Med Chem. 1996 Jun 7;39(12):2293-301
PMID: 8691424
-
Cationic [99mTcIII(DIARS)2(SR)2]+ complexes as potential myocardial perfusion imaging agents (DIARS = o-phenylenebis(dimethylarsine);SR- = thiolate).
J Med Chem. 1996 Mar 15;39(6):1253-61
PMID: 8632432
-
Sustained activation of phospholipase D via adenosine A3 receptors is associated with enhancement of antigen- and Ca(2+)-ionophore-induced secretion in a rat mast cell line.
J Pharmacol Exp Ther. 1996 Feb;276(2):837-45
PMID: 8632357
-
Adenosine A3 receptor stimulation and cerebral ischemia.
Eur J Pharmacol. 1994 Sep 22;263(1-2):59-67
PMID: 7821362
-
125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
Mol Pharmacol. 1994 May;45(5):978-82
PMID: 8190112
-
Adenosine A3 receptors in mast cells.
Trends Pharmacol Sci. 1994 Jan;15(1):13-4
PMID: 8140652
-
Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.
J Med Chem. 1994 Mar 4;37(5):636-46
PMID: 8126704
-
Molecular cloning and characterization of the human A3 adenosine receptor.
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10365-9
PMID: 8234299
-
The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.
J Biol Chem. 1993 Aug 15;268(23):16887-90
PMID: 8349579
-
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432-6
PMID: 1323836
-
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
J Pharmacol Exp Ther. 1989 Dec;251(3):888-93
PMID: 2600819
-
Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.
Naunyn Schmiedebergs Arch Pharmacol. 1980 Sep;313(3):179-87
PMID: 6253840
-
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
PMID: 4202581
-
Pharmacological characterization of novel A3 adenosine receptor-selective antagonists.
Neuropharmacology. 1997 Sep;36(9):1157-65
PMID: 9364471
-
Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.
J Neurosci. 1997 Jan 15;17(2):607-14
PMID: 8987783
-
Adenosine A3 receptor stimulation inhibits migration of human eosinophils.
J Leukoc Biol. 1997 Oct;62(4):465-8
PMID: 9335316
-
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
J Med Chem. 1997 Aug 1;40(16):2596-608
PMID: 9258367
-
Adenosine A3 receptors: novel ligands and paradoxical effects.
Trends Pharmacol Sci. 1998 May;19(5):184-91
PMID: 9652191